Polymorphisms of methylenetetrahydrofolate reductase gene as the genetic predispositions of coronary artery diseases in eastern India

Journal of Cardiovascular Disease Research

Volumn 1, Issue 3, 2010, Pages 152-157

  Dhar, Soujatya ^a   Chatterjee, Sumana ^a   Ray, Saumitra ^a   Dutta, Anjanlal ^a   Sengupta, Bani ^a   Chakrabarti, Shila ^a  

^a VIVEKANANDA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Allele; case control; methylenetetrahydrofolate reductase; multiple logistic regression; polymorphism

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2);

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; FAMILY HISTORY; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENOTYPE; HUMAN; HYPERTENSION; INDIA; MAJOR CLINICAL STUDY; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE GENE; PRIORITY JOURNAL; RISK FACTOR; SMOKING;

EID: 79953057062     PISSN: 09753583     EISSN: 09762833     Source Type: Journal    
DOI: 10.4103/0975-3583.70922     Document Type: Article

References (35)

1. Gupta R, Joshi P, Mohan V, Reddy KS, Yusuf S. Epidemiology and causation of coronary heart disease and stroke in India. Heart 2008;94:16-26.
2. Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global burden of disease study. Lancet 1997;349:1498-504. (Pubitemid 27216360)
3. Grundy SM, Ba1ady GJ, Criqui MH, Fletcher G, Greenland P, Hiratzka LF. Primary prevention of coronary heart disease: Guidelines from Framingham. Circulation 1998;97:1876-87.
4. Zak I, Niemiec P, Sarecka B, Balcerzyk A, Ciemniewski Z, Rudowska E, et al. Carrier-state of D allele in ACE gene insertion/deletion polypolymorphism is associated with coronary artery disease, in contrast to the C677-T transition in the MTHFR gene. Acta Biochimica Polonica 2003;50:527-33.
5. The Homocysteine Studies Collaboration. Homocysteine and risk of ischemic heart disease and stroke-a meta analysis. JAMA 2002;288:2015-22.
6. Wald DS, Law M, Morris JK. Homocysteine and cardiovascular disease: Evidence on causality from a meta analysis. BMJ 2002;325:1202-6. (Pubitemid 35398783)
7. Welch GN, Loscalzo J. Homocysteine and atherothrombosis. N Engl J Med 1998;338:1042-50. (Pubitemid 128753793)
8. Rimm EB, Willett WC, Hu FB, Sampson L, Colditz GA, Manson JE, et al. Folate and vitamin B6 from diet and supplements in relation to risk of coronary heart disease among women. JAMA 1998;279:359-64. (Pubitemid 28133864)
9. Verhoef P, Stampfer MJ, Buring JE, Gaziano M, Allen RH, Stabler SP, et al. Homocysteine metabolism and risk of myocardial infarction: Relation with vitamins B6, B12 and folate. Am J Epidemiol 1996;143:845-59.
10. Vinukonda G. Plasma homocysteine and methylenetetrahydrofolate reductase gene polymorphism in human health and disease: An Update. Int J Hum Genet 2008;8:171-9.
11. Goyette P, Pai A, Milos R, Frosst P, Tran P, Chen Z, et al. Gene structure of human and mouse methylenetetrahydrofolate reductase (MTHFR). Mamm Genome 1998;9:652-6. (Pubitemid 28355328)
12. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, et al. A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995;10:111-3.
13. Clarke R, Daly L, Robinson K, Naughten E, Cahalane S, Fowler B, et al. Hyperhomocysteinemia: An independent risk factor for vascular disease. N Engl J Med 1991;324:1149-55.
14. Refsum H, Ueland PM. Homocysteine and cardiovascular disease. Annu Rev Med 1998;49:31-62. (Pubitemid 28197439)
15. Langman LJ, Cole DE. Homocysteine: Cholesterol of the 90s? Clin Chim Acta 1999;286:63-80. (Pubitemid 29406101)
16. Folsom AR, Nieto FJ, McGovern PG, Tsai MY, Malinow MR, Eckfeldt JH, et al. Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms, and B vitamins: The Atherosclerosis Risk in Communities (ARIC) study. Circulation 1998;98:204-10. (Pubitemid 28337610)
17. Chambers JC, Ireland H, Thompson E, Reilly P, Obeid OA, Refsum H, et al. Methylenetetrahydrofolate reductase 677 C-T mutation and coronary heart disease risk in UK indian asians. Arterioscler Thromb Vasc Biol 2000;20:2448-52.
18. Jacques PF, Bostom AG, Williams RR, Ellison RC, Eckfeldt JH, Rosenberg IH, et al. Relation between folate status a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation 1996;93:7-9. (Pubitemid 26006560)
19. Christensen B, Frosst P, Lussier-Cacan S, Selhub J, Goyette P, Rosenblatt DS, et al. Correlation of a common mutation in the methylenetetrahydrofolate reductase gene with plasma homocysteine in patients with premature coronary artery disease. Arterioscler Thromb Vasc Biol 1997;17:569-73. (Pubitemid 27133149)
20. Brattstrom L, Wilcken DE, Ohrvik J, Brudin L. Common methylenetetrahydrofolate reductase gene mutation leads to hyperhomocysteinemia but not to vascular disease: The result of a meta-analysis. Circulation1998;98: 2520-6. (Pubitemid 29001189)
21. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16:1215.
22. Jang Y, LeeJH, Huh KB, Kim OY, Topham D, Balderston B. Influence of alcohol consumption and smoking habits on cardiovascular risk factors and antioxidant status in healthy Korean men. Nutr Res 2000;20:1213-1227.
23. Gulec S, Aras O, Akar E, Tutar E, Omurlu K, Avci F, et al. Methylenetetrahydrofolate reductase gene polymorphism and risk of premature myocardial infarction. Clin Cardiol 2001;24:281-4. (Pubitemid 32285308)
24. Linnebank M, Montenarh M, Klsch H, Linnebank A, Schnez K, Schweichel D, et al. Common genetic variants of homocysteine metabolism in ischemic stroke: A case-control study. Eur J Neurol 2005;12:614-8.
25. Iqbal MP, Fatima T, Parveen S, Yousuf FA, Shafiq M, Mehboobali N, et al. Lack of association of methylenetetrahydrofolate reductase 677C>T mutation with coronary artery disease in a Pakistani population. J Mol Genet Med 2005;1:26-32.
26. Nair KG, Nair SR, Ashavaid TF, Dalal JJ, Eghlim FF. Methylenetetrahydrofolate reductase gene mutation and hyperhomocysteinemia as a risk factor for coronary heart disease in the Indian population. J Assoc Phys India 2002;50:9-15.
27. Mukherjee M, Joshi S, Bagadi S, Dalvi M, Rao A, Shetty KR. A low prevalence of the C677T mutation in the methylenetetrahydrofolate reductase gene in Asian Indians. Clin Genet 2002;61:155-9. (Pubitemid 36372622)
28. Refsum H, Yajnik CS, Gadkari M, Schneede J, Vollset SE, Orning L, et al. Hyperhomocysteinemia and elevated methylmalonic acid indicate a high prevalence of cobalamin deficiency in Asian Indians. Am J Clin Nutr 2001;74:233-41. (Pubitemid 32702491)
29. Dalal AB, Tewari D, Tewari S, Sharma MK, Pradhan M, Gupta UR, et al. Association of coronary artery disease with polymorphisms of angiotensin-converting enzyme and methylenetetrahydrofolate reductase gene. Indian Heart J 2006;58:330-5. (Pubitemid 44903920)
30. RamaDevi AR, Govindaiah V, Ramakrishna G, Naushad SM. Prevalence of methylene tetrahydrofolate reductase polymorphism in South Indian population. Curr Sci 2004;86:440-3. (Pubitemid 39160285)
31. Kalita J, Srivastava R, Bansal V, Agarwal S, Misra UK. Methylenetetrahydrofolate reductase gene polymorphism in Indian stroke patients. Neurol India 2006;54:260-3. (Pubitemid 44341760)
32. Agarwal DP. Genetic predisposition to cardiovascular diseases. Int J Hum Genet 2001;1:233-41.
33. Higgins M. Epidemiology and prevention of coronary heart disease in families. Am J Med 2000;108:387-95. (Pubitemid 30162957)
34. Friedlander Y, Arbogast P, Schwartz SM, Marcovina SM, Austin MA, Rosendaal FR, et al. Family history as a risk factor for early onset myocardial infarction in young women. Atherosclerosis 2001;156:201-7. (Pubitemid 32429613)
35. da Silva PM. The genetic contribution to coronary disease: The genetic factors related to lipid metabolism. Rev Port Cardiol 1999;18:735-47.